Mezzion

Beta

KRX Filings & Disclosures 2026

Risk Factors

• • No derivative contracts entered in FY2025
• • No market risk quantification disclosed in financial notes

Management Discussion & Analysis

• • Revenue KRW 7.91B, down 8.2% YoY; Operating loss KRW 16.77B, up 17.3%; Net loss KRW 34.93B, up 79.3%
• • Decline in sales due to livestock epidemic impact; increased SG&A by KRW 2.01B from ongoing clinical trial costs

Business Overview

• • Udenafil-based Fontan patient treatment NDA planned resubmission after FDA protocol approval in March 2023, with ongoing additional clinical trials
• • ADPKD treatment with Udenafil entered preclinical stage in April 2025, collaborating with Mayo Clinic for efficacy evaluation

What are the latest Mezzion DART filings in 2026?

Mezzion (KRX code 140410) has filed an annual report on March 20, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.

When did Mezzion file its most recent annual report?

Mezzion filed its most recent annual report on March 20, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.

What is Mezzion's KRX stock code?

Mezzion's KRX stock code is 140410. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 140410 to look up all Mezzion disclosures on DART, or browse them here on SignalX with AI-powered English analysis.

How often does Mezzion file with DART?

Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.

What is the difference between annual, half-year, and quarterly reports in Korea?

An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for Mezzion.

Where can I find Mezzion financial data and KIFRS metrics?

SignalX extracts KIFRS consolidated financial data from Mezzion annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.